Q'Apel Medical, a California-based private medical device company focused on neurovascular interventions, announced on Monday that it has named Jodie Fam as its new chief executive officer.
Fam succeeds R King Nelson, who retires after heading the firm for last five years and is to continue to work on the company's board of directors.
Fam has more than two decades of experience in the medical device industry. She has served in executive leadership positions at multiple medical device companies including public and several venture-backed start-ups. She has worked as Q'Apel's chief marketing officer and general manager for the company's international business. She has also worked as the CEO of AblaCare (now May Health) and in senior management positions at Route 92 Medical, Medina Medical (acquired by Medtronic), CardioKinetix and Concentric Medical (acquired by Stryker). She has served in senior clinical, sales and marketing positions with Guidant Corporation, Johnson & Johnson and Mallinckrodt Medical.
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke